These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 16390851)

  • 1. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
    Yen TH; Huang CC; Lin HH; Huang JY; Tian YC; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
    Nephrol Dial Transplant; 2006 Apr; 21(4):1046-52. PubMed ID: 16390851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation.
    Locasciulli A; Bruno B; Alessandrino EP; Meloni G; Arcese W; Bandini G; Cassibba V; Rotoli B; Morra E; Majolino I; Alberti A; Bacigalupo A;
    Bone Marrow Transplant; 2003 Feb; 31(4):295-300. PubMed ID: 12621466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H
    Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
    Lee WC; Wu MJ; Cheng CH; Chen CH; Shu KH; Lian JD
    Am J Kidney Dis; 2001 Nov; 38(5):1074-81. PubMed ID: 11684562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B in renal transplant patients.
    Peres AA; Dias EA; Chesky M; Alvares-da-Silva MR; Jobim LF; Gonçalves LF; Manfro RC
    Transpl Infect Dis; 2005 Jun; 7(2):51-6. PubMed ID: 16150090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
    Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH
    Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
    Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
    Shitrit AB; Kramer MR; Bakal I; Morali G; Ben Ari Z; Shitrit D
    Ann Thorac Surg; 2006 May; 81(5):1851-2. PubMed ID: 16631684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Knöll A; Boehm S; Hahn J; Holler E; Jilg W
    J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
    Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV reactivation after kidney transplantation.
    Berger A; Preiser W; Kachel HG; Stürmer M; Doerr HW
    J Clin Virol; 2005 Feb; 32(2):162-5. PubMed ID: 15653420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.
    Wang SS; Chou NK; Chi NH; Hsu RB; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Lai MY; Chu SH
    Transplant Proc; 2006 Sep; 38(7):2138-40. PubMed ID: 16980024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
    Hammond SP; Borchelt AM; Ukomadu C; Ho VT; Baden LR; Marty FM
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
    Ahn HJ; Kim MS; Kim YS; Kim SI; Huh KH; Ju MK; Ahn SH; Han KH
    J Med Virol; 2007 Nov; 79(11):1655-63. PubMed ID: 17854044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difficulties of managing severe hepatitis B virus reactivation.
    Roche B; Samuel D
    Liver Int; 2011 Jan; 31 Suppl 1():104-10. PubMed ID: 21205146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of impact of hepatitis C virus coinfection in end-stage renal disease patients with hepatitis B virus infection.
    Moutinho RS; Perez RM; Pace FH; Ferreira AS; Cendoroglo M; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    Transplant Proc; 2005 Jun; 37(5):2080-2. PubMed ID: 15964344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.
    Yeo W; Chan PK; Hui P; Ho WM; Lam KC; Kwan WH; Zhong S; Johnson PJ
    J Med Virol; 2003 Aug; 70(4):553-61. PubMed ID: 12794717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.